ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
ETFs
The best ASX ETFs for new investors in 2026
Growth Shares
My top ASX stock picks for long-term wealth
How to invest
What could $10,000 invested in ASX shares look like in 20 years?
Share Market News
2 dead-easy Australian stocks to buy with $500 right now
How to invest
How compounding turns even small ASX share investments into big wealth
How to invest
How to double your ASX share portfolio without chasing risky stocks
Blue Chip Shares
BHP and these ASX 200 shares could rise 15% to 30%
Growth Shares
3 unstoppable trends driving ASX stocks higher
How to invest
How to know when to buy, hold, or sell ASX shares
How to invest
Over 55s can't afford to ignore the stock market. Here's why
Growth Shares
Forget gold bars: this ASX stock could be the real wealth preserver
How to invest
How to build a $2,000 monthly income from ASX shares
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.